{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:26:10Z","timestamp":1761431170136,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jcyt.2015.07.015","type":"journal-article","created":{"date-parts":[[2015,9,5]],"date-time":"2015-09-05T00:33:18Z","timestamp":1441413198000},"page":"1329-1331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antifungal T cells\u2014progress in manufacture and prospects for the clinic"],"prefix":"10.1016","volume":"17","author":[{"given":"David","family":"Gottlieb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2015.07.015_bib1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcyt.2015.07.015_bib2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcyt.2015.07.015_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2015.07.015_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation","volume":"345","author":"Rooney","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2015.07.015_bib5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","article-title":"Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines","volume":"362","author":"Peggs","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2015.07.015_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/blood-2012-05-430413","article-title":"Immunotherapeutic strategies to prevent and treat human herpes virus (HHV) 6 reactivation post allogeneic stem cell transplant","volume":"121","author":"Gerdemann","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.07.015_bib7","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3109\/14653249.2012.663486","article-title":"Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients","volume":"14","author":"Blyth","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.07.015_bib8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/TP.0b013e31823328c0","article-title":"BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses","volume":"92","author":"Blyth","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2015.07.015_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4049\/jimmunol.165.1.381","article-title":"T\u00a0cell vaccination in mice with invasive pulmonary aspergillosis","volume":"165","author":"Cenci","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcyt.2015.07.015_bib10","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.0900961","article-title":"Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination","volume":"183","author":"Bozza","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcyt.2015.07.015_bib11","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1182\/blood-2002-01-0265","article-title":"Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies","volume":"100","author":"Hebart","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.07.015_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jim.2008.02.014","article-title":"Enumeration of functionally active anti-Aspergillus T-cells in human peripheral blood","volume":"335","author":"Beck","year":"2008","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jcyt.2015.07.015_bib13","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.4049\/jimmunol.1400776","article-title":"Identification of immunogenic antigens from Aspergillus fumigatus by direct multiparameter characterization of specific conventional and regulatory CD4+ T cells","volume":"193","author":"Bacher","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcyt.2015.07.015_bib14","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1182\/blood-2010-12-325084","article-title":"Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans","volume":"117","author":"Stuehler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.07.015_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2249.2005.02699.x","article-title":"Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen","volume":"139","author":"Ramadan","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcyt.2015.07.015_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/bmt.2008.271","article-title":"Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy","volume":"43","author":"Tramsen","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.07.015_bib17","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3109\/14653249.2012.704013","article-title":"Robust polyfunctional T-helper 1 responses to multiple fungal antigens from a cell population generated using an environmental strain of Aspergillus fumigatus","volume":"14","author":"Gaundar","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.07.015_bib18","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood-2005-04-1660","article-title":"Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus","volume":"107","author":"Beck","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.07.015_bib19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/infdis\/jit237","article-title":"Characterization of the T-cell-mediated immune response against the Aspergillus fumigatus proteins Crf1 and catalase 1 in healthy individuals","volume":"208","author":"Jolink","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jcyt.2015.07.015_bib20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcyt.2012.11.014","article-title":"Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes","volume":"15","author":"Tramsen","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.07.015_bib21","doi-asserted-by":"crossref","first-page":"10660","DOI":"10.1073\/pnas.1312789111","article-title":"Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection","volume":"111","author":"Kumaresan","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcyt.2015.07.015_bib22","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood-2010-12-322610","article-title":"Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154","volume":"118","author":"Khanna","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.07.015_bib23","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","article-title":"Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation","volume":"106","author":"Perruccio","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.07.015_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.22738","article-title":"Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: proof of principle, description, and clinical and research implications","volume":"110","author":"Miceli","year":"2007","journal-title":"Cancer"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324915010002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324915010002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:21:20Z","timestamp":1761430880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324915010002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1465324915010002"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.07.015","relation":{},"ISSN":["1465-3249"],"issn-type":[{"type":"print","value":"1465-3249"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal T cells\u2014progress in manufacture and prospects for the clinic","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2015 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}